Biomarker-Driven Pharmacological Treatment of Adolescents With Autism Spectrum Disorder With Gabapentin

Clinical trial NCT05063656 · COMPLETED

Trial details

NCT number: NCT05063656
Sponsor: David Cochran
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Autism Spectrum Disorder

Start date: 2022-02-04
Primary completion: 2025-12-31
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.